HYUNDAI BIOSCIENCE CO., LTD. Periodic Report
AI summary · Not investment advice
Hyundai Bio sold KRW 0.5 billion in Q3 and lost KRW 5.2 billion from its main business, with sales down 16.5% from a year earlier.
Operating profit · 3 months
KRW -5.2 billion
Key facts
- Revenue (3 months)
- KRW 461.8 million
- Net income (3 months)
- KRW -6.8 billion
- Period
- Q3 (cumulative 2026.01.01 ~ 2026.09.30)
- Revenue (prior-year 3 months)
- KRW 553.1 million
- Revenue (year to date)
- KRW 1.3 billion
- Operating profit (prior-year 3 months)
- KRW -4.6 billion
- Operating profit (year to date)
- KRW -15.4 billion
- Net income (prior-year 3 months)
- KRW -7.0 billion
- Net income (year to date)
- KRW -23.7 billion
Commentary
AI commentary · Not investment advice
What happened
Hyundai Bio reported its third-quarter results for 2026 on a consolidated basis. Sales for the three months were KRW 461.8 million. That is 16.5% lower than the same three months a year earlier, when sales were KRW 553.1 million.
In the company's terms
Operating profit (profit from the core business) for the three months was a loss of KRW 5.17 billion. A year earlier, the loss for the same period was KRW 4.62 billion. Net income (the final profit after taxes and all other items) for the three months was a loss of KRW 6.84 billion. A year earlier, the loss was KRW 7.00 billion.
What changes for shareholders
For the year to date, from January 1 to September 30, sales were KRW 1.31 billion. The operating loss was KRW 15.37 billion. The net loss was KRW 23.72 billion.
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
H